Take on complex biomarker and advanced cytometric challenges through an extensive flow cytometry offering, spanning complex/translational biomarkers, mass cytometry, and use at clinical trial scale for primary, secondary or experimental endpoints.
Guide your decision-making from discovery to the clinic with exploratory biomarker insights from our Translational Biomarker Solutions (TBS). From initial feasibility and development to advanced validation, testing and production, the experienced TBS team offers collaborative support and fit-for-purpose assays using a diverse toolbox of platforms. Personalized biomarker support is also available to help drive your development from bench to commercialization.
Quality laboratory management made easy. ELMS manages third-party laboratory performance with a rigorous identification, qualification, monitoring and reporting plan to ensure high quality and actionable data. The ELMS team will also support esoteric testing through LabCorp’s Specialty Testing Group, a distinctive combination of specialty laboratories offering discrete esoteric testing capabilities and expertise.